Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 586 AL 600

Insight into amyloid structure using chemical probes

Reinke AA, Gestwicki JE.

Chem Biol Drug Des. 2011 Jun;77(6):399-411. doi: 10.1111/j.1747-0285.2011.01110.x. Epub 2011 Apr 26.

Increased plasma levels of lipocalin 2 in mild cognitive impairment

Choi J, Lee HW, Suk K.

J Neurol Sci. 2011 Jun 15;305(1-2):28-33. doi: 10.1016/j.jns.2011.03.023. Epub 2011 Apr 3.

[Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior]

Shioda N, Yamamoto Y, Han F, Moriguchi S, Fukunaga K.

Yakugaku Zasshi. 2011 Apr;131(4):505-11. doi: 10.1248/yakushi.131.505.

Diagnostic dilemma in an elderly woman

Khan F, Curtice M.

BMJ. 2011 Apr 6;342:d969. doi: 10.1136/bmj.d969.

Alzheimer's disease: the challenge of the second century

Holtzman DM, Morris JC, Goate AM.

Sci Transl Med. 2011 Apr 6;3(77):77sr1. doi: 10.1126/scitranslmed.3002369.

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O; Florbetaben Study Group.

Lancet Neurol. 2011 May;10(5):424-35. doi: 10.1016/S1474-4422(11)70077-1. Epub 2011 Apr 8.

Amyloid-dependent and amyloid-independent stages of Alzheimer disease

Hyman BT.

Arch Neurol. 2011 Aug;68(8):1062-4. doi: 10.1001/archneurol.2011.70. Epub 2011 Apr 11.

Posterior cortical atrophy: a rare visual variant of Alzheimer's disease

Gafoor VA, Jose J, Saifudheen K, Musthafa M.

Neurol India. 2011 Mar-Apr;59(2):297-9. doi: 10.4103/0028-3886.79154.

The involvement of multiple caregivers in cognitive-behavior therapy for anxiety in persons with dementia

Robinson CM, Paukert A, Kraus-Schuman CA, Snow AL, Kunik ME, Wilson NL, Teri L, Stanley MA.

Aging Ment Health. 2011 Apr;15(3):291-8. doi: 10.1080/13607860903493374.

Reversible limbic encephalitis in a person with Alzheimer's disease

Klimkowicz-Mrowiec A, Furgal M, Slowik A, Szczudlik A.

J Am Geriatr Soc. 2011 Apr;59(4):757-9. doi: 10.1111/j.1532-5415.2011.03340.x.

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study

Barak Y, Plopski I, Tadger S, Paleacu D.

Int Psychogeriatr. 2011 Nov;23(9):1515-9. doi: 10.1017/S1041610211000743. Epub 2011 Apr 15.

Delusion of reduplication of tongue accompanied by dangerous self-treatments in a patient with Alzheimer's disease

Hayashi H, Suzuki A, Matsumoto Y, Otani K.

Aust N Z J Psychiatry. 2011 May;45(5):427. doi: 10.3109/00048674.2011.566548.

Persons with mild or moderate Alzheimer's disease use a basic orientation technology to travel to different rooms within a day center

Lancioni GE, Perilli V, Singh NN, O'Reilly MF, Sigafoos J, Bosco A, De Caro MF, Cassano G, Pinto K, Minervini M.

Res Dev Disabil. 2011 Sep-Oct;32(5):1895-901. doi: 10.1016/j.ridd.2011.03.020. Epub 2011 Apr 17.

A phase II trial of huperzine A in mild to moderate Alzheimer disease

Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Apr 19;76(16):1389-94. doi: 10.1212/WNL.0b013e318216eb7b.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias